|1.||Kovalenko, A L: 1 article (01/2002)|
|2.||Lychakov, A V: 1 article (01/2002)|
|3.||Shevchuk, M K: 1 article (01/2002)|
|4.||Savateeva, T N: 1 article (01/2002)|
|5.||Kolbasov, S E: 1 article (01/2002)|
|6.||Gillespie, G Y: 1 article (09/2001)|
|7.||Achen, M G: 1 article (09/2001)|
|8.||Slagle-Webb, B: 1 article (09/2001)|
|9.||Tulchinsky, E: 1 article (09/2001)|
|10.||Debinski, W: 1 article (09/2001)|
07/06/2001 - "Hepatocyte growth factor (HGF) is a pleotropic polypeptide that can function as a morphogen, motogen, mitogen, angiogen, carcinogen, and tumor suppressor, depending on the target cell and tissue. "
06/01/2000 - "As VEGF165 is a potent angiogen in human tumours, we suggest that heparin enriched in 2.5 kDa species and 5.0 kDa species especially should be exploited as a combined anti-coagulant and specific adjuvant anti-angiogenic agent in cancer patients who require anti-coagulant therapy."
09/01/2001 - "Because VEGF-D activates VEGF receptor 2 and 3, receptors important for tumor angiogenesis, it may represent an X-linked/AP-1-regulated onco-angiogen in human GBM. "
|3.||Glioblastoma (Glioblastoma Multiforme)
|4.||Cardiovascular Diseases (Cardiovascular Disease)
|1.||Vascular Endothelial Growth Factor D
|2.||Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
|3.||Hepatocyte Growth Factor (Growth Factor, Hepatocyte)